Global Intensity Modulated Radiotherapy (IMRT) Market Size to Reach USD 3.74 Billion in 2032 | Emergen Research

Increasing government incentives for cancer management is a key factor driving Intensity Modulated Radiotherapy (IMRT) Market revenue growth

Vancouver, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The global Intensity Modulated Radiotherapy (IMRT) market size was USD 2.21 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% during the forecast period, according to latest analysis by Emergen Research. Increasing government incentives for cancer management and rising demand for non-invasive cancer treatments are key factors driving market revenue growth.

IMRT customizes radiation intensity to match the distinct size and shape of tumor, ensuring precise delivery of high-dose radiation, thereby potentially enhancing the effectiveness of treatment. IMRT prevents the irradiation of healthy organs and tissues, leading to a reduction in both side effects and complications. In addition, early detection of cancer to reduce cancer mortality and high demand for non-invasive treatments are rising demand for IMRT. For example, on 20 February 2023, Varian, which is a Siemens Healthineers subsidiary, partnered with Nova Scotia Health to lead the digital revolution in the health system's all-encompassing oncology services. Over a span of five years, the Oncology Transformation Project (OTP) is expected to build upon and merge Nova Scotia Health's current Varian software assets, creating a cohesive, interconnected ecosystem of multi-disciplinary oncology software and services.

Proton therapy has gained in popularity in the recent years as a possible treatment to deliver good results while limiting toxicity in an elderly patient population. Approximately 31 hospitals around the U.S. have invested millions of dollars to create proton therapy facilities. IMPT specializes in delivering a precise, high dosage of proton therapy that is suited to the tumor's unique structure and size. This therapy is capable of directly delivering this targeted, high-dose proton treatment to the tumor while exactly adhering to the complicated dimensions. According to the American Society of Clinical Oncology (ASCO), as compared to traditional radiotherapy, proton treatment typically delivers 60% less radiation to healthy tissue around the target location while giving a significant dosage to the tumor itself.

However, high cost associated with the equipment & training, lack of skilled radiologist/oncologist, and complexity involved in treatment are key factors, which could restrain market revenue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Scope of Research

Report DetailsOutcome
Market Size in 2022USD 2.21 Billion
CAGR (2023–2032)5.4%
Revenue Forecast To 2032USD 3.74 Billion
Base Year For Estimation2022
Historical Data2019-2021
Forecast Period2023–2032
Quantitative UnitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report CoverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments CoveredRadiation type, application, end-user, and region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country ScopeU.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies ProfiledHitachi, Ltd., Varian Medical Systems, Inc., Accuray Incorporated, Elekta, IBA Proton Therapy, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., Proton International London Ltd. Company, Koninklijke Philips N.V., and Mirion Technologies, Inc.
Customization Scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Major Companies and Competitive Landscape

The global IMRT market is moderately fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective IMRT solutions. Some major players included in the global IMRT market report are:

  • Hitachi, Ltd.
  • Varian Medical Systems, Inc.
  • Accuray Incorporated
  • Elekta
  • IBA Proton Therapy
  • Mevion Medical Systems
  • Panacea Medical Technologies Pvt. Ltd.
  • Proton International London Ltd. Company
  • Koninklijke Philips N.V.
  • Mirion Technologies, Inc.

Strategic Development

  • On 13 June 2023, Northwell Lenox Hill Hospital's Cancer Institute became the first in New York State by adopting the HyperSight imaging solution. This innovative technology utilizes advanced cone-beam computed tomography to provide quicker and clearer images throughout the radiation therapy treatment procedure.
  • On 13 June 2023, Grovecourt Capital Partners, which is a private equity firm, purchased Premier Radiology Services, which is a teleradiology company with a national presence headquartered in Miami, FL.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @                                                                                                                                                                     

Some Key Highlights From the Report

  • The proton radiation segment is expected to account for largest revenue share in the global IMRT market over the forecast period. This is due to increasing need for proton beam to target and destroy tumor cells while protecting a larger proportion of the surrounding healthy tissue. This not only results in reduced side effects, but additionally also reduces the risk of subsequent malignancies caused by radiation exposure. Proton treatment is also used to treat noncancerous growths such as brain tumors, spinal cord tumors, pancreatic cancer, and lung cancers, among others.
  • The breast cancer segment is expected to register steadily fast revenue growth rate in the global IMRT market during the forecast period. This is due to rising number of breast cancer patients and related fatalities. According to World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer and resulted in 685,000 deaths globally in 2020. Radiation therapy addresses residual, minuscule cancerous remnants within the breast tissue and/or lymph nodes, thereby reducing the risk of cancer recurrence occurring on the chest wall.The cancer treatment centers segment is expected to register moderately fast revenue growth rate in the global IMRT market over the forecast period. This is because certain cancer tests and treatment require constant monitoring on regular basis, for which cancer centers are best suited. Various hospitals collaborate with cancer centers to provide important cancer services such as systemic anti-cancer therapy.
  • The North America market accounted for largest revenue share in the global IMRT market in 2022 owing to the presence of state-of-the-art healthcare institution along with better insurance medical coverage for patients. According to the American Society of Clinical Oncology (ASCO), there are over 3.8 million women who are living with breast cancer in the U.S. In addition, increasing medical investments for cancer research and medical infrastructure is also expected to drive market revenue growth of this region during the forecast period.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Emergen Research has segmented the global Intensity Modulated Radiotherapy (IMRT) market on the basis of radiation type, application, end-use, and region:

  • Radiation Type Outlook (Revenue, USD Billion; 2019-2032)
    • Electron radiation
    • Proton radiation
    • Photon radiation
    • Carbon-ion radiation
  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Breast cancer
    • Prostate cancer
    • Gastrointestinal (GI) cancer
    • Brain cancer
    • Lung cancer
    • Gynecological cancers
    • Others
  • End-use Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals
    • Cancer treatment centers
    • Radiation oncology clinics
    • Academic medical centers
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

 Curated Reports You Shouldn't Miss: Dive In Now!

Endoscopic Vessel Harvesting Market, By Product (Endoscopes, Accessories, EVH Systems), By Usability (Reusable, Disposable), By Vessel Types (Radial Artery, Saphenous Vein), By Application, and By Region Forecast to 2032

Atherectomy Devices Market, By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Peripheral Vascular, Cardiovascular), By End-Use (Hospitals and Surgical Centers), and By Region Forecast to 2032

Nucleotide Market, By Application (Sports Nutrition, Infant Formula, Nutritional Drink, and Others), By Form (Liquid and Powder), By Industry (Food Beverages, Medical and Healthcare Industry, and Others), and By Region Forecast to 2032

Kidney Renal Function Test Market, By Product (Dipsticks, Reagents, and Disposables), By Type (Urine Tests and Blood Tests), By End-Use (Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes), and By Region Forecast to 2032

Therapeutic Endoscopy Devices Market, By Product (Endoscope, Mechanical Endoscopic Equipment, and Others), By Hygiene (Single use, Sterilization, and Others), By Application, By End-Use, and By Region Forecast to 2032

Ultrasonic Dissection Market, By Product (Hand-Held Device, Ultrasonic Generators, and Accessories), By Application (General Surgery, Gynecology, Plastic Surgery, Urology, and Others), By End-Use, and By Region Forecast to 2032

Bone Conduction Hearing Systems Market, By Product Type (Bone Anchored Hearing Aids and Traditional Bone Conduction Hearing Aids), By Patient Type (Children/Pediatrics and Adults), By End-Use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Explore Our Blogs and Insights Section:

Read our Press Release @

Contact Data